Mitchell Kapoor
Stock Analyst at HC Wainwright & Co.
(1.16)
# 3,458
Out of 4,784 analysts
296
Total ratings
31.14%
Success rate
-18.04%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LXEO Lexeo Therapeutics | Reiterates: Buy | $23 | $4.10 | +460.98% | 6 | Mar 26, 2025 | |
| ALMS Alumis | Reiterates: Buy | $15 | $5.64 | +165.96% | 10 | Mar 26, 2025 | |
| NGNE Neurogene | Maintains: Buy | $55 → $50 | $14.52 | +244.35% | 14 | Mar 25, 2025 | |
| VERV Verve Therapeutics | Reiterates: Buy | $15 | $5.22 | +187.36% | 5 | Mar 25, 2025 | |
| ABEO Abeona Therapeutics | Reiterates: Buy | $15 | $4.97 | +201.81% | 2 | Mar 24, 2025 | |
| KRRO Korro Bio | Reiterates: Buy | $115 | $17.44 | +559.40% | 11 | Mar 20, 2025 | |
| SRPT Sarepta Therapeutics | Reiterates: Sell | $75 | $70.41 | +6.52% | 7 | Mar 19, 2025 | |
| RLYB Rallybio | Reiterates: Buy | $5 | $0.64 | +681.13% | 19 | Mar 17, 2025 | |
| RNAC Cartesian Therapeutics | Maintains: Buy | $45 → $40 | $14.54 | +175.10% | 16 | Mar 14, 2025 | |
| LYEL Lyell Immunopharma | Reiterates: Neutral | $1 | $0.54 | +84.77% | 11 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $73 → $75 | $35.06 | +113.92% | 35 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.63 | - | 8 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $63.84 | - | 34 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $18.08 | +508.41% | 14 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $8.07 | +271.75% | 1 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $44 | $20.32 | +116.54% | 13 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $9.77 | +207.06% | 18 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $65 | $36.99 | +75.72% | 2 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $12.50 | +260.00% | 5 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.51 | +874.85% | 15 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $5 | $1.27 | +295.26% | 5 | Dec 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.33 | - | 12 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $14 | $1.48 | +845.95% | 8 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $6 | $2.00 | +200.00% | 5 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.36 | +561.76% | 14 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40,000 → $610,000 | $5.00 | +12,199,900.00% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $1.98 | - | 4 | Jun 2, 2023 |
Lexeo Therapeutics
Mar 26, 2025
Reiterates: Buy
Price Target: $23
Current: $4.10
Upside: +460.98%
Alumis
Mar 26, 2025
Reiterates: Buy
Price Target: $15
Current: $5.64
Upside: +165.96%
Neurogene
Mar 25, 2025
Maintains: Buy
Price Target: $55 → $50
Current: $14.52
Upside: +244.35%
Verve Therapeutics
Mar 25, 2025
Reiterates: Buy
Price Target: $15
Current: $5.22
Upside: +187.36%
Abeona Therapeutics
Mar 24, 2025
Reiterates: Buy
Price Target: $15
Current: $4.97
Upside: +201.81%
Korro Bio
Mar 20, 2025
Reiterates: Buy
Price Target: $115
Current: $17.44
Upside: +559.40%
Sarepta Therapeutics
Mar 19, 2025
Reiterates: Sell
Price Target: $75
Current: $70.41
Upside: +6.52%
Rallybio
Mar 17, 2025
Reiterates: Buy
Price Target: $5
Current: $0.64
Upside: +681.13%
Cartesian Therapeutics
Mar 14, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $14.54
Upside: +175.10%
Lyell Immunopharma
Mar 13, 2025
Reiterates: Neutral
Price Target: $1
Current: $0.54
Upside: +84.77%
Mar 12, 2025
Maintains: Buy
Price Target: $73 → $75
Current: $35.06
Upside: +113.92%
Mar 7, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.63
Upside: -
Mar 6, 2025
Reiterates: Buy
Price Target: n/a
Current: $63.84
Upside: -
Mar 5, 2025
Reiterates: Buy
Price Target: $110
Current: $18.08
Upside: +508.41%
Mar 5, 2025
Initiates: Buy
Price Target: $30
Current: $8.07
Upside: +271.75%
Feb 25, 2025
Reiterates: Buy
Price Target: $44
Current: $20.32
Upside: +116.54%
Feb 18, 2025
Reiterates: Buy
Price Target: $30
Current: $9.77
Upside: +207.06%
Feb 13, 2025
Reiterates: Buy
Price Target: $65
Current: $36.99
Upside: +75.72%
Feb 7, 2025
Reiterates: Buy
Price Target: $45
Current: $12.50
Upside: +260.00%
Jan 22, 2025
Reiterates: Buy
Price Target: $5
Current: $0.51
Upside: +874.85%
Dec 24, 2024
Reiterates: Neutral
Price Target: $5
Current: $1.27
Upside: +295.26%
Dec 16, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.33
Upside: -
Dec 10, 2024
Maintains: Buy
Price Target: $7 → $14
Current: $1.48
Upside: +845.95%
Nov 20, 2024
Maintains: Neutral
Price Target: $7 → $6
Current: $2.00
Upside: +200.00%
Nov 19, 2024
Reiterates: Buy
Price Target: $9
Current: $1.36
Upside: +561.76%
Sep 6, 2023
Maintains: Buy
Price Target: $40,000 → $610,000
Current: $5.00
Upside: +12,199,900.00%
Jun 2, 2023
Reiterates: Neutral
Price Target: n/a
Current: $1.98
Upside: -